ATAD2 is within a commonly amplified region (8q24) across multiple cancer types [95] and its expression seems to be a predictor of poor prognosis in BC [143] and in other tumors, as in prostate cancer [144]–[145]. The gene discussed is ATAD2; the disease is cancer.